{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-061471","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2025-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.995871+00:00","generated_at":"2026-05-18T09:28:54.898580+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Jasper Therapeutics shareholders elect directors, ratify PwC, approve say-on-pay","bullets":["Elected Kurt von Emster, Scott Brun, and Vishal Kapoor as Class I directors with >8.4M votes each.","Ratified PwC as independent auditor for FY 2025: 11,992,658 for, 18,646 against.","Advisory say-on-pay approved: 8,108,299 for, 536,022 against, 9,718 abstentions.","Advisory vote on frequency favored every 1 year (8,580,886 votes); company will hold annual say-on-pay votes.","Turnout ~80% (12,014,527 of 15,022,122 shares represented)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-061471","json":"https://secwatch.observer/filing/0001213900-25-061471.json","markdown":"https://secwatch.observer/filing/0001213900-25-061471.md","text":"https://secwatch.observer/filing/0001213900-25-061471.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390025061471/0001213900-25-061471-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390025061471/ea0248135-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:28:54.898580+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}